Korean J Gastroenterol.  2008 Feb;51(2):84-88.

Screening and Diagnosis for Pancreatic Cancer

Affiliations
  • 1Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. leejk@skku.edu

Abstract

Pancreatic cancer has an extremely poor prognosis mainly because the diagnosis is made late. Therefore, screening and early diagnosis are essential ways to improve the patient's survival. There is no cost-effective screening method in general population because pancreatic cancer is relatively uncommon. Some patients belonging to high-risk groups such as hereditary pancreatic cancer, familial pancreatic caner kindred, new-onset diabetes in eldery patients, can be targets of secondary screening. To date, multi-detector CT is the standard method for proper diagnosis of pancreatic cancer. EUS play roles for identifying small lesion and cytologic examination. Other modalities like endoscopic retrograde cholangiopancreatography (ERCP), MRI/MRCP, positron emission tomography (PET), or laparoscopy, can be used selectively for the diagnosis and assessment of resectability

Keyword

Pancreatic cancer; Screening; Diagnosis

MeSH Terms

Cholangiopancreatography, Endoscopic Retrograde
Humans
Laparoscopy
Magnetic Resonance Imaging
Pancreatic Neoplasms/*diagnosis
Tomography, X-Ray Computed
Tumor Markers, Biological
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr